Published in Biochim Biophys Acta on November 09, 1982
The cobalamin-binding protein in zebrafish is an intermediate between the three cobalamin-binding proteins in human. PLoS One (2012) 0.83
Expression of transcobalamin II mRNA in human tissues and cultured fibroblasts from normal and transcobalamin II-deficient patients. Biochem J (1994) 0.80
A single rainbow trout cobalamin-binding protein stands in for three human binders. J Biol Chem (2012) 0.79
Entry of murine retrovirus into mouse fibroblasts. Virology (1983) 1.96
Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med (2001) 1.63
Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry (1986) 1.53
[Homocysteine and cardiovascular disease]. Ugeskr Laeger (2001) 1.39
Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology (1984) 1.38
[Diagnosis and vitamin B12 deficiency]. Tidsskr Nor Laegeforen (2001) 1.38
Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. Proc Natl Acad Sci U S A (1980) 1.35
Effect of sialoadenectomy and synthetic human urogastrone on healing of chronic gastric ulcers in rats. Gut (1986) 1.23
Effect of the cobalt-N coordination on the cobamide recognition by the human vitamin B12 binding proteins intrinsic factor, transcobalamin and haptocorrin. Eur J Biochem (1991) 1.22
Molecular dissection of the intrinsic factor-vitamin B12 receptor, cubilin, discloses regions important for membrane association and ligand binding. J Biol Chem (1999) 1.21
Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev (1999) 1.19
Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc Natl Acad Sci U S A (1996) 1.17
Isolation of the human placenta receptor for epidermal growth factor-urogastrone. Nature (1979) 1.15
Epidermal growth factor inhibits cysteamine-induced duodenal ulcers. Gastroenterology (1983) 1.15
Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis (2001) 1.12
Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology (1988) 1.07
Quantitation of epidermal growth factor in the rat. Identification and partial characterization of duodenal EGF. Scand J Gastroenterol (1983) 1.05
Volume of blood removed for analytical purposes during hospitalization of low-birthweight infants. Clin Chem (1981) 1.04
Solubilization and isolation of the human placenta receptor for epidermal growth factor-urogastrone. J Biol Chem (1980) 1.00
Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat. Histochemistry (1988) 1.00
Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology (1986) 0.99
C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest (1998) 0.98
Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase. Scand J Clin Lab Invest (2003) 0.96
Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scand J Clin Lab Invest (2004) 0.95
Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis. Br J Cancer (1998) 0.94
Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med (2003) 0.94
Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands. Gut (1984) 0.94
Variants of type-C retroviruses from DBA/2 mice: protein-structural and biological properties. Virology (1983) 0.94
Renal origin of rat urinary epidermal growth factor. Regul Pept (1984) 0.93
Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand J Gastroenterol (1993) 0.93
Activation of C-type virus during chemically induced leukemogenesis in mice. Cancer Res (1978) 0.93
Expression of the epidermal growth factor system in human endometrium during the menstrual cycle. Mol Hum Reprod (2005) 0.92
Conformational changes of transcobalamin induced by aquocobalamin binding. Mechanism of substitution of the cobalt-coordinated group in the bound ligand. J Biol Chem (2000) 0.92
Holotranscobalamin - a sensitive marker of cobalamin malabsorption. Eur J Clin Invest (1999) 0.91
Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat. Gut (1998) 0.90
Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Res (2000) 0.90
Characterization of the particulate and soluble acceptor for transcobalamin II from human placenta and rabbit liver. Biochim Biophys Acta (1980) 0.89
Transcobalamin from cow milk: isolation and physico-chemical properties. Biochim Biophys Acta (1996) 0.89
Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. Mutat Res (1999) 0.88
Epidermal growth factor transcription, translation, and signal transduction by rat type II pneumocytes in culture. Am J Respir Cell Mol Biol (1992) 0.88
Variation with age of reference values for P-cobalamins. Scand J Haematol (1983) 0.88
Unsaturated and cobalamin saturated transcobalamin I and II in normal human plasma. Scand J Clin Lab Invest (1977) 0.87
Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem (2001) 0.87
Quantification of melanoma cell-specific MART-1 mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR. Clin Chem (2000) 0.86
Synthesis and secretion of a cobalamin-binding protein by HT 29 cell line. Biochem J (1991) 0.86
The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine. J Intern Med (2000) 0.86
Binding of cobalamin and cobinamide to transcobalamin from bovine milk. Biochemistry (1995) 0.86
Cobalamin binding proteins in human seminal plasma. Scand J Clin Lab Invest (1992) 0.86
Adrenergic effects on exocrine secretion of rat submandibular epidermal growth factor. Gut (1984) 0.85
Systemic administration of insulin-like growth factor I (IGF-I) causes growth of the rat prostate. J Urol (1997) 0.85
A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer (1995) 0.85
Systemically administered trefoil factors are secreted into the gastric lumen and increase the viscosity of gastric contents. Br J Pharmacol (2006) 0.84
Characterization and immunohistochemical localization of rat salivary cobalamin-binding protein and comparison with human salivary haptocorrin. Biochim Biophys Acta (1985) 0.84
Fetal effects of epidermal growth factor deficiency induced in rats by autoantibodies against epidermal growth factor. Pediatr Res (1995) 0.84
Vasoactive intestinal polypeptide and acetylcholine stimulate exocrine secretion of epidermal growth factor from the rat submandibular gland. Regul Pept (1986) 0.84
Spontaneous expression of C-type virus in DBA/2 mice is associated with an increased rate of mortality, independent of neoplastic disease. J Virol (1985) 0.84
Transcellular transport of vitamin B(12) in LLC-PK1 renal proximal tubule cells. J Am Soc Nephrol (2001) 0.84
Determination of cobalamins in biological material. II. The cobalamins in human plasma and erythrocytes after desalting on nonpolar adsorbent material, and separation by one-dimensional thin-layer chromatography. Anal Biochem (1983) 0.84
C-type virus protein p30 in blood from inbred mice correlates with their later incidence of leukemia. Infect Immun (1977) 0.83
Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol (1995) 0.83
Urinary excretion of epidermal growth factor and Tamm-Horsfall protein in three rat models with increased renal excretion of urine. Regul Pept (1997) 0.83
Processing of epidermal growth factor in the rat submandibular gland by Kallikrein-like enzymes. Growth Factors (1994) 0.83
Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer. Scand J Clin Lab Invest (1999) 0.82
Purification and characterization of rabbit haptocorrin. Biochim Biophys Acta (1981) 0.82
Cobalamin and its binding protein in rat milk. Scand J Clin Lab Invest (1989) 0.82
Calibrated user-friendly reverse transcriptase-PCR assay: quantitation of epidermal growth factor receptor mRNA. Clin Chem (1998) 0.82
Epidermal growth factor in the rat lung. Histochemistry (1991) 0.82
Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology (1997) 0.82
Distribution of i.v. administered epidermal growth factor in the rat. Regul Pept (1988) 0.81
Exocrine secretion of epidermal growth factor from Brunner's glands. Stimulation by VIP and acetylcholine. Regul Pept (1983) 0.81
Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy. Diabet Med (1989) 0.81
Adrenergic effects on secretion of amylase from the rat salivary glands. Digestion (1988) 0.81
Seasonal variation of DNA damage and repair in patients with non-melanoma skin cancer and referents with and without psoriasis. Mutat Res (1998) 0.81
Amphiregulin is expressed in primary cultures of prostate myofibroblasts, fibroblasts, epithelial cells, and in prostate tissue. Prostate Cancer Prostatic Dis (1998) 0.81
Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol (1993) 0.81
Epidermal growth factor in urine from patients with urinary bladder tumors. Eur Urol (1988) 0.81
The membrane fraction of homogenized rat kidney contains an enzyme that releases epidermal growth factor from the kidney membranes. Biochim Biophys Acta (1991) 0.80
Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. Regul Pept (2003) 0.80
Sensitivity to nitrogen mustard relates to the ability of processing DNA damage in Chinese hamster ovary cells. Pharmacol Toxicol (2000) 0.80
Secretion of acid, gastrin, and cobalamin-binding proteins by the fetal pig stomach: developmental regulation by cortisol. Exp Physiol (1994) 0.80
Psoriasis patients with basal cell carcinoma have more repair-mediated DNA strand-breaks after UVC damage in lymphocytes than psoriasis patients without basal cell carcinoma. Cancer Lett (2000) 0.80
Early urinary changes in Tamm-Horsfall protein and epidermal growth factor in diabetic children. Pediatr Nephrol (2001) 0.80
Epidermal growth factor and haptocorrin in nasal secretion. Scand J Clin Lab Invest (1990) 0.79
Mechanism of chemical activation of expression of the endogenous ecotropic murine leukemia provirus Emv-3. J Virol (1990) 0.79
Epidermal growth factor and insulin-like growth factor I upregulate the expression of the epidermal growth factor system in rat liver. J Hepatol (2000) 0.79
A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients. Cancer Res (1990) 0.79
Murine xenotropic type C viruses. V. Biologic and structural differences among three cloned retroviruses isolated from kidney cells from one NZB mouse. Virology (1984) 0.79
Exocrine and endocrine secretion of renin and epidermal growth factor from the mouse submandibular glands. Regul Pept (1984) 0.79
Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy. J Endocrinol (1995) 0.78
Transcobalamin I and other human R-binders: purification, structural, spectral and physiological studies. Scand J Haematol (1978) 0.78
Primary structure of human intrinsic factor: progress report on cyanogen bromide fragmentation. Scand J Clin Lab Invest (1978) 0.78
The urinary excretion of epidermal growth factor in the rat is reduced by aprotinin, a proteinase inhibitor. Regul Pept (1990) 0.78
Somatic mutation detection in human biomonitoring. Pharmacol Toxicol (1996) 0.78
Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs. Dig Dis Sci (1994) 0.78
Binding of epidermal growth factor from man, rat and mouse to the human epidermal growth factor receptor. Biochim Biophys Acta (1985) 0.78
Renal uptake and excretion of epidermal growth factor from plasma in the rat. Regul Pept (1990) 0.78
Chronic treatment with epidermal growth factor induces growth of the rat ventral prostate. Scand J Urol Nephrol (2001) 0.77
Does epidermal growth factor play a role in the action of sucralfate? Scand J Gastroenterol Suppl (1987) 0.77
Chronic systemic treatment with epidermal growth factor induces hypergastrinaemia in Goettingen minipigs. Scand J Gastroenterol (1995) 0.77